ResearcherSecond Military Medical UniversityActive in the last 2 years
Xiaobo Peng
Matched on ORCID iD 0000-0003-0655-5296; OpenAlex author ID A5103212233. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- KAT8 catalyzes the acetylation of SEPP1 at lysine 247/249 and modulates the activity of CD8+ T cells via LRP8 to promote anti-tumor immunity in pancreatic canc… Co-author DOI 10.1186/s13578-025-01356-3↗
- Autologous ex vivo expanded NK cells combined with PD-1 inhibitor improved ascitic fluid immune microenvironment of peritoneal metastatic pancreatic cancer: a … Co-author PMID 36777837↗
- Application of natural killer cells in pancreatic cancer. Co-author DOI 10.3892/ol.2021.12908↗
- LKB1 obliterates Snail stability and inhibits pancreatic cancer metastasis in response to metformin treatment. Co-author DOI 10.1111/cas.13591↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianbao Zhan · 4 shared papers, 2018–2025 · strength 0.75
- Paper KAT8 catalyzes the acetylation of SEPP1 at lysine 247/249 and modulates the activity of CD8+ T cells via LRP8 to promot… DOI 10.1186/s13578-025-01356-3↗
- Paper Autologous ex vivo expanded NK cells combined with PD-1 inhibitor improved ascitic fluid immune microenvironment of per… PMID 36777837↗
- Paper Application of natural killer cells in pancreatic cancer. DOI 10.3892/ol.2021.12908↗
- Ling Chen · 2 shared papers, 2021–2023 · strength 0.34
- Dan Ding · 1 shared paper, 2025 · strength 0.33
- Zhongfei Zhu · 1 shared paper, 2025 · strength 0.33
- Gang Nie · 1 shared paper, 2025 · strength 0.33
- Yanfang Liu · 1 shared paper, 2023 · strength 0.18
- Meng Guo · 1 shared paper, 2023 · strength 0.18
- Xiaorong Xu · 1 shared paper, 2018 · strength 0.09
- Lele Song · 1 shared paper, 2018 · strength 0.09
- Lixing Zhan · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.